多式人工肝支持对急性-慢性肝衰竭的有效性:单中心队列研究
Jing-Yi Ding1, Wen-Xin Li1, Ju Wang2
1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
概括
在急性至慢性肝功能衰竭 (ACLF) 患者中,三合一人工肝支持 (ALS) 显著改善了生存率. 这种先进的治疗有效清除毒素和减少炎症,提供比双模性ALS更大的好处.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 人工器官支持的人工器官支持
- 关键护理医学 关键护理医学
背景情况:
- 多式人工肝支持 (ALS) 已在急性肝衰竭模型中显示出有效性.
- 急性至慢性肝衰竭 (ACLF) 是一个重大的临床挑战,需要有效的治疗策略.
研究的目的:
- 评估 ACLF 患者的三节式 ALS 与双节式 ALS 的治疗效果.
- 评估不同ALS模式对ACLF患者的生存率和生化标志物的影响.
主要方法:
- 在2014年至2019年期间接受多模式ALS的ACLF患者的回顾性分析.
- 患者被分为三模性和双模性ALS组,用于控制基线差异的倾向性得分匹配.
- 单次治疗后的生存率和实验室参数与治疗结束后的生存率进行了比较.
主要成果:
- 倾向性得分匹配导致47对对进行比较.
- 与双模组相比,三模组ALS组的28天 (91.5%vs. 76.6%) 和90天 (91.5%vs. 74.5%) 的存活率显著更高.
- 类ALS导致胆素,胆酸,-胺转移酶和性酸酶显著减少,同时增加IL-8和MIF的清除,并且是较低死亡率的独立预测因子.
结论:
- 与双模性ALS相比,三模性ALS为ACLF患者提供了生存益处.
- 三模性ALS的增强疗效归因于其在毒素清除和炎症抑制方面的卓越能力.
- 特里莫达尔ALS代表了管理ACLF的有前途的治疗选择.
相关概念视频
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...